EMA regular press briefing on COVID-19
The European Medicines Agency (EMA) is holding a press briefing to provide an update on its most recent activities in the context of the COVID-19 pandemic.
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communication Department).
This is EMA’s last regular press briefing before the summer. EMA will resume the bi-weekly briefings in early September. EMA will also continue to organise ad-hoc press conferences as necessary and appropriate in the coming weeks.
The press briefing will be held in English. No translations will be provided.